Easy-to-handle devices for immediate compatibility with standard characterization, imaging, and analysis techniques. The capture devices can be manufactured from a wide range of materials to adjust to end-user application (reculturing/proliferation of cells, high-resolution fluorescence imaging etc)
Our modular design offers up to ten S-MDCs to be used for optimal CTC capture.
We aim real-time and quality-controlled quantitative CTC measurement to accelerate clinical decision-making.
End user :
Our research use clientele are made up of academic labs and institutions, CROs, and pharmaceutical industry.
CTC-Station© reproduces in vivo conditions to ensure optimal capture of CTC with low contamination levels for subsequent analysis. This fully-automatized benchtop platform allows the recovery of captured CTC and their insertion into conventional downstream biological analysis.
CTC-STATION will be deployed into academic research centers, clinical research institutes, and pharmaceutical industries to accelerate the adoption process of our technology into well-established CTC workflows, limited to research purposes.
End user :
CTC-PHERESIS provides the clinician a solution for the continuous, high-volume, and direct capture of cancer cells in blood. This innovation can fit an aphaeretic device able to screen a maximum volume of patient blood directly from a peripheral vein. The large blood volume in combination with the highly specific S-MDC, could lead to increased cancer cells counts and better representativeness. Facing the inadequacy of current approaches with clinical routine, S-PHERESIS system is designed to be portable, and compatible with standard blood-processing medical devices and consumables. S-PHERESIS is also designed to be compatible with conventional downstream biology techniques used for cell analysis at the cellular and molecular level.
Reach out to us !
We develop solutions that meet your needs.